Immune Therapeutics Files New Drug Application for Lodonol in Kenya to Target HIV Epidemic
Immune Therapeutics announced that the Kenya Pharmacy and Poison Board filed IMUN’s New Drug Application (NDA) for Lodonal, its lead drug candidate, thereby accepting the NDA for a full…
Read More...
Read More...